Chromatography based purification of retro virus spikes
Presenting the data for purification of Retro virus using ion exchange chromatography where the condition for purification was optimized.
Early discovery due diligence of immuno target through multi pronged approaches
Our approach to informed decision-making during early discovery stage to create novel, best-in-class drugs.
Effect of Container Closure Systems on Stability of Pharmaceutical Products
Case studies on how Syngene handled unique problems in Stability Testing arising from packaging material.
Efficient Scale Up of Therapeutic Antibody Manufacturing Processes
Syngene’s ‘first-time-right’ Technology Transfer approach to achieve timely clinical and commercial milestones.
Mechanistic insights into drug-drug interactions from large-scale toxicogenomics data
How to manage the risk of drug-drug interactions in drug development and during poly therapy especially with elderly patients.
Profiling CEACAM7 as a potential target for pancreatic cancer
Demonstrating the therapeutic edge of targeting CEACAM7 in pancreatic cancer using an integrative approach between biology and bioinformatics.